MADRIGAL PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNTA PHARMACEUTICALS CORP (SNTA)
CIK: 0001157601
Period of Report: 2012-12-12

Reporting Person: Kovner Bruce (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-12	Common Stock	A	2325581	$8.60	Acquired	3273281	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7096852	Direct
Common Stock	125000	Indirect
Common Stock	125000	Indirect
Common Stock	125000	Indirect
Common Stock	125000	Indirect
Common Stock	475000	Indirect
Common Stock	475000	Indirect
Common Stock	475000	Indirect
Common Stock	475000	Indirect
Common Stock	7761716	Indirect

Footnotes

F1: These shares are owned directly by KFO Holdings LLC ("KFO") and indirectly by the Reporting Person as the sole member of KFO.

F2: These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.